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Abstract
Background: Besides cognitive decline, Alzheimer’s disease (AD) leads to physical disability, need for help and
permanent institutional care. The trials investigating effects of exercise rehabilitation on physical functioning of
home-dwelling older dementia patients are still scarce. The aim of this study is to investigate the effectiveness of
intensive exercise rehabilitation lasting for one year on mobility and physical functioning of home-dwelling
patients with AD.
Methods: During years 2008-2010, patients with AD (n = 210) living with their spousal caregiver in community are
recruited using central AD registers in Finland, and they are offered exercise rehabilitation lasting for one year. The
patients are randomized into three arms: 1) tailored home-based exercise twice weekly 2) group-based exercise
twice weekly in rehabilitation center 3) control group with usual care and information of exercise and nutrition.
Main outcome measures will be Guralnik’s mobility and balance tests and FIM-test to assess physical functioning.
Secondary measures will be cognition, neuropsychiatric symptoms according to the Neuropsychiatric Inventory,
caregivers’ burden, depression and health-related quality of life (RAND-36). Data concerning admissions to
institutional care and the use and costs of health and social services will be collected during a two year follow-up.
Discussion: To our knowledge this is the first large scale trial exploring whether home-dwelling patients with AD
will benefit from intense and long-lasting exercise rehabilitation in respect to their mobility and physical
functioning. It will also provide data on cost-effectiveness of the intervention.
Trial registration: ACTRN12608000037303
Background
Dementia is the most important disease group leading
to disability and requiring social and health care among
older individuals [1]. The most prevalent of dementing
illnesses (55-80%) is Alzheimer’s disease which leads to
gradual and often steady decline of cognitive function-
ing, to various behavioural and psychological symptoms
and physical disability [2]. Disabilities lead to loss of
autonomy, require help and support as well as institu-
tional care. Dementia with its consequences is also very
expensive for the society [1].
One pivotal problem in dementia leading to need for
help and institutional care is decline in mobility. Loco-
motion gets stiff, walking decelerates and falls are com-
mon [3]. The stiffness and emerging disabilities makes
caregivers’ work demanding. Going outdoors, getting
dressed and undressed as well as transfers from one
place to another become challenging [1]. This process is
accelerated by patient’s progressive sarcopenia, weight
loss and muscular weakness which impede body control
and predisposes to falls [4].
Some earlier studies have suggested that physical exer-
cise may be beneficial in dementia. Physical activity and
regular exercise training may slow down cognitive
decline [5,6], and it has positive effects on cognition
among those with cognitive decline [7]. Exercise
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alleviates depression and reduces behavioural symptoms
in dementia patients [7,8]. There are several controlled
trials testing effectiveness of endurance or strength
training among patients with dementia or in samples
with a large proportion of patients with dementia. Most
of the trials have a low number of participants and,
therefore, low power to show effectiveness. In addition,
many of the trials are not randomized. A meta-analysis
of these trials showed a small but significant effect on
strength and endurance outcomes [9]. Majority of these
trials have been performed in nursing homes or in long-
term care. One randomized study in a nursing home
setting has shown that intensive, long-lasting exercise
training may even improve physical functioning of Alz-
heimer’s patients [10]. According to the trials showing
effectiveness on physical functioning, the training pro-
gram should be intensive, long-lasting and versatile.
We found only four clinical exercise trials targeted
on home-dwelling patients with dementia [8,11-13].
Three of them were performed with very low number
of patients (N = 29-81) [11-13] and two of them did
not show any effectiveness [11,12]. Teri’s study [8] was
targeted to improve behavioural symptoms in demen-
tia. Thus, there are still only few rigorous randomized
trials investigating the effectiveness of physical rehabi-
litation among home-dwelling patients with dementia.
Although some studies have shown promising effects
of exercise on physical functioning among institutiona-
lized patients with dementia, there are no such studies
among home-dwelling patients with Alzheimer’s dis-
ease (AD).
We are testing intensive exercise training performed
twice weekly either at patient’s home or in a day centre
and lasting for one year on patients Alzheimer’s disease
(AD). The primary aim of this study is to investigate the
effects of exercise on AD patients’ mobility and physical
functioning. The secondary aims are to assess the effects
of exercise interventions on patients’ neuropsychiatric
symptoms and cognition. We also investigate the effects
of intervention on the use and costs of health care ser-
vices, admissions of AD patients to permanent institu-
tional care (cost-effectiveness), falls and mortality. The
effects on the caregivers’ quality of life will also be
assessed.
Methods
General design
This is a multicenter, controlled intervention trial with a
prospective, randomized design. The aim is to study the
effects of two exercise interventions, one performed at
AD patients’ home for one hour twice a week, and
another performed at rehabilitation day centres for four
hours twice a week. The interventions will last for one
year, and they are compared with usual care. The study
has been approved by the Ethics Committee of the Hel-
sinki University Central Hospital. Informed consent has
been obtained from each patient and/or their spousal
caregiver before any study procedure which are per-
formed according to good clinical practice. An executive
committee (KHP, TES, RST) is responsible for the plan-
ning, conduct and monitoring of the study.
Participants
The study was started in 2008 by posting a letter to a
random sample of patients receiving reimbursement for
AD medication according to the centralized Drug
Imbursement Register of the Social Insurance Institution
of Finland (Kela), and his/her spouse living at the same
address. All these patients had undergone detailed diag-
nostic assessments before acquiring reimbursement for
their AD medication (e.g. cognitive and neuropsycholo-
gical tests, neuroimaging and laboratory tests). The out-
line of the exercise study was described, and they were
invited to participate.
Besides AD and spouse requirement, the inclusion cri-
teria are:
- living in the greater Helsinki area (Helsinki - Espoo
- Vantaa)
- age over 64 years
- no terminal disease, no severe hemiparesis
- independent mobility - with walking devices if
needed
- frailty: at least one fall during last year, slowed
walking speed, or weight loss during one year
All the spouses of the AD patients showing interest in
participation are sent a questionnaire to confirm the ful-
filment of the inclusion criteria and they are further
interviewed via telephone about the frailty criteria,
mobility and diseases. Those couples fulfilling inclusion
criteria are invited for the first study nurse visit. At the
beginning of the first visit the couples are given written
and oral information of the study and they are asked to
sign an informed consent. Both patients and their spou-
sal caregivers give consent. In case of the AD patient’s
poor capability of judgement the spousal caregiver gives
proxy’s consent for both spouses.
Study procedures
The baseline study visit lasts about two hours and
includes interview of both spouses’ demographic data,
diagnoses, medications used, and baseline use of health
and social services. The diagnoses and medications are
confirmed from medical records provided by the cou-
ples. Charlson comorbidity index is calculated to assess
the severity and prognostic value of the participants’ dis-
ease burden [14].
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The AD patients are assessed by Clinical Dementia
Rating Scale (CDR) [15], Minimental State Examination
(MMSE) [16], verbal flow [17,18], clock drawing test
[19], Mininutritional Assessment (MNA) [20], Neurop-
sychiatric Inventory (NPI) [21,22], Cornell depression
test [23], mobility tests and balance tests [24], and the
Functional Independence Measure (FIM) [25]. Patients’
weight, blood pressure (with 10 min rest and recorded
in a sitting position), heart rate and handgrip strength
[26] are assessed on each visit. Falls and fractures are
recorded with the aid of diaries kept by caregivers and
recorded on each visit.
The spousal caregivers are assessed by the Zarit bur-
den scale [27], Geriatric Depression Scale (GDS) [28],
RAND36 [29,30] and mobility and balance tests [24]. At
six months the caregivers are asked to give feedback for
the study and their satisfaction is assessed.
The couples are randomized in clusters of 30. After
assessing 30 couples with eligibility and frailty criteria
confirmed and agreeing to consent the study, the rando-
mization is performed. Couples are randomly allocated
by means of computer-generated random numbers to
three arms: to receive home rehabilitation, day care
rehabilitation or to receive the usual care. The study
nurse calls by telephone to a randomization staff mem-
ber who has not seen the couples neither their clinical
records. She assigns the next number from the compu-
ter and the group assignment to the patient.
Participating couples are assessed by two study nurses
four times during the year: at baseline, and at 3, 6, and 12
months. In addition, those remaining in the community
will be invited for a follow-up visit at 24 months. The
study assessment procedures are described in table 1.
Use of health and social services, institutionalizations and
death dates on both the patients and the caregivers will
be retrieved from the central registers until two years
from baseline measurements.
The flow chart of the study is described in figure 1.
Intervention
A total of 210 patients will be randomized in three
groups (70 per each arm) as follows:
Table 1 Study assessment procedures and timetable.
Assessment1 Telehone
interview
Baseline
visit
3 month
visit
6 month
visit
12 month
visit
24 month
visit
AD patient
Inclusion criteria X
Demographics, diagnoses, drugs X
CDR X X
MMSE X X X
Verbal flow, clock drawing test X X X X X
MNA X
Weight, BMI X X X X X
Mobility and balance tests by Guralnik X X X X X
FIM X X X X X
NPI X X
Grip strength, blood pressure, heart rate X X X X X
Cornell depression scale X X
Falls and fractures X X X X
Use of health and social services, admission to permanent
institutional care, mortality
X X X X
Spousal caregiver
Demographics, diagnoses, drugs X
Zarit burden scale X X X
GDS X X
RAND-36 QOL X X X
Mobility and balance tests by Guralnik X X
Use of health and social services, mortality X X X X
1 CDR = Clinical dementia Rating Scale (Hughes et al 1982) (0.5 suggests possible dementia, 1 mild, 2 moderate, and 3 severe dementia); MMSE = Minimental
State Examination (Folstein et al. 1972); MNA = Mininutritional Assessment (Guigoz et al. 2002) (< 24 suggests risk for malnutrition or malnourishment); BMI =
Body mass index; Guralnik’s mobility tests (Guralnik et al. 1994); FIM = Measure of functioning (Pollak et al. 1996); NPI = Neuropsychiatric inventory (Cummings et
al. 1994, 1997); Cornell = depression test (Alexopoulos et al. 1988); Zarit burden scale (Zarit et al. 1980), GDS = Geriatric depression scale (Yesavage et al. 1982-3);
RAND-36 = Measure of health related quality of life (Parker et al. 2006)
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Figure 1 Flow chart of the study.
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Intervention
A geriatrician performs comprehensive geriatric assess-
ment prior the intervention and makes the rehabilitation
plan including also nutritional care.
1. Home-based physical exercise and rehabilitation
procedures (one hour twice a week for 12 months) are
performed by physiotherapy professionals of an expert
organization (Suomen Fysiogeriatria), with long-term
experience of dementia exercise rehabilitation. Interven-
tions are tailored according to the patient’s and care-
giver’s needs (for example: training transfers, stair
climbing, balance training, executive functioning or
dual-tasking).
2. Day rehabilitation centre-based physical exercise
and rehabilitation (4 hours twice a week for 12 months)
is organized and performed by professionals of dementia
physiotherapy at two day rehabilitation centres (with
gym and experience) performing the day care rehabilita-
tion. Intervention consists of endurance, balance, and
strength training as well as dual task training and exer-
cises directed to improve executive functioning. Taxi
transportation and lunch are provided for participants
during the intervention days.
The intervention is provided up to one year or until
patient is admitted to permanent institutional care.
Patients randomized to the control group receive the
usual care in normal health care system, but they are
provided with oral and written advice on nutrition and
exercise by the study organization.
As a nutritional advice, all patients receive advice to
ensure a sufficient intake of energy and protein [4] and
to take 20 μg of vitamin D supplements per day [31].
Outcome measurements
Primary outcome measures are changes in patients’
mobility assessed by the tests described by Guralnik et
al [24] and in physical functioning according to the FIM
measure [25].
Secondary outcome measures are changes in patients’
cognition by verbal flow [17] and MMSE [16], neuropsy-
chiatric symptoms by NPI [21,22] and Cornell [23],
number of falls, and permanent institutionalizations and
time spent at home. Changes in caregivers’ satisfaction,
burden by the Zarit burden scale [27], depression by the
GDS [28], health-related quality of life by the RAND-36
[29,30] will be measured as secondary outcomes.
Total mortality, use and costs of health and social care
services of both spouses as well as cost-effectiveness of
the intervention will be measured up to 24 months from
the beginning of the baseline measurements.
Statistical analyses
Sample size was calculated based on the FIM measure
[25]. With an estimated standard deviation 20, and type
I error 5%, 80% power, 63 patients would be needed in
each group to show a 10-point difference between
groups. With estimated 10% drop outs in each group
about 70 patients are needed in each group. Data will be
analyzed on intention-to-treat basis. Imputation method
“the last observation carried forward” (LOCF) and
“Worst-rank score"-principle will be used.
In these baseline findings, for the continuous variables,
descriptive values were expressed by means with stan-
dard deviations (SD) and medians with range. For the
variables with a normal (Gaussian) distribution, statisti-
cal comparisons between the groups are made by using
an analysis of variance. If the variables have a non-nor-
mal distribution or ordinal level, statistical comparison
between groups was made using the Kruskall-Wallis
test. Measures with a discrete distribution were
expressed as percentages (%) and analysed by Chi-
Square or Fischer’s exact test when appropriate.
Discussion
This trial investigates the effects of intense, long-lasting
physical exercise on home-dwelling patients with AD. It
has two active intervention arms which are compared
with usual care. One third of patients receive home-
based tailored exercise twice a week one hour at the
time for one year or until the patient is admitted to per-
manent institutional care. Another third of patients are
receiving versatile exercise training including endurance,
balance, and strength training as well as dual task train-
ing and exercises directed to improve executive func-
tioning. This intervention is provided in day centers for
four hours/day twice weekly for one year or until the
patient is admitted to permanent institutional care.
There are several strengths in our study. All partici-
pants have an established diagnosis of AD because all
are recruited from the drug register. This register
requires definite diagnosis based on cognitive tests, dis-
ability, laboratory tests, and CT scan or MRI scan for
the AD drug reimbursement. All participants suffer
from frailty, and have therefore a need for exercise reha-
bilitation. Thus, the findings should be applicable in real
life. The exercise training is intense and long-lasting,
thus, reinforcing effectiveness of the intervention. The
used resources and costs will be counted in detail.
However, there are also several challenges in this
study. First, the population is old and frail with many
comorbidities, and, thus, vulnerable to competing causes
of complications and deaths. The second challenge
relates to a sufficient difference to be attained between
the groups with our intervention. Contamination of the
control group is probably not a problem, because exer-
cise rehabilitation is rarely available for dementia
patients in Finland unless they are the Second World
War veterans [32], in practice over 83 years of age in
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2008. Although the FIM has been developed to measure
outcomes of rehabilitation and validated among very old
patients [25], it is not very clear how the FIM measure
will respond to change in functioning as a consequence
of exercise intervention in patients with AD. It was also
challenging to find suitable scales to measure change in
cognition in this heterogeneous group consisting of all
stages of dementia.
To our knowledge, this is the first large scale interven-
tion trial exploring the effects of exercise on physical
functioning among home-dwelling patients with demen-
tia. This study will provide data whether exercise will
have effect on physical functioning and use of health
services among home-dwelling AD patients at risk for
functional decline and institutional care.
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